Why to target G‐quadruplexes using peptides: Next‐generation G4‐interacting ligands
Journal of Peptide Science · 2023
DOI: 10.1002/psc.3491 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Peptide Science, 2023. Verfasst von Taniya Sharma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, India. Hauptthemen laut MEDLINE: DNA, Oligonucleotides. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 334 Literaturangaben. Gefördert von: Department of Biotechnology (DBT) Govt of India, Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Guanine‐rich oligonucleotides existing in both DNA and RNA are able to fold into four‐stranded DNA secondary structures via Hoogsteen type hydrogen‐bonding, where four guanines self‐assemble into a square planar arrangement, which, when stacked upon each other, results in the formation of higher‐order structures called G‐quadruplexes. Their distribution is not random; they are more frequently present at telomeres, proto‐oncogenic promoters, introns, 5′‐ and 3′‐untranslated regions, stem cell markers, ribosome binding sites and so forth and are associated with various biological functions, all of which play a pivotal role in various incurable diseases like cancer and cellular ageing. Several studies have suggested that G‐quadruplexes could not regulate biological processes by themselves; instead, various proteins take part in this regulation and can be important therapeutic targets. There are certain limitations in using whole G4‐protein for therapeutics purpose because of its high manufacturing cost, laborious structure prediction, dynamic nature, unavailability for oral administration due to its degradation in the gut and inefficient penetration to reach the target site because of the large size. Hence, biologically active peptides can be the potential candidates for therapeutic intervention instead of the whole G4‐protein complex. In this review, we aimed to clarify the biological roles of G4s, how we can identify them throughout the genome via bioinformatics, the proteins interacting with G4s and how G4‐interacting peptide molecules may be the potential next‐generation ligands for targeting the G4 motifs located in biologically important regions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, India.
- Department of Fruit Science, College of Horticulture, Mojerla, Sri Konda Laxman Telangana State Horticultural University, Budwel, Telangana, India.
ORCID-Profile: Sarika Saxena
Förderung
- Department of Biotechnology (DBT) Govt of India
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Sharma, T., Kundu, N., Kaur, S., Shankaraswamy, J., & Saxena, S. (2023). Why to target G‐quadruplexes using peptides: Next‐generation G4‐interacting ligands. Journal of Peptide Science. https://doi.org/10.1002/psc.3491
Vancouver
Sharma T, Kundu N, Kaur S, Shankaraswamy J, Saxena S. Why to target G‐quadruplexes using peptides: Next‐generation G4‐interacting ligands. Journal of Peptide Science. 2023. doi:10.1002/psc.3491
BibTeX
@article{Sharma2023,
author = {Sharma, Taniya and Kundu, Nikita and Kaur, Sarvpreet and Shankaraswamy, Jadala and Saxena, Sarika},
title = {Why to target G‐quadruplexes using peptides: Next‐generation G4‐interacting ligands},
journal = {Journal of Peptide Science},
year = {2023},
doi = {10.1002/psc.3491}
}
EUVIMED